Pfizer scientists say it’s not enough to work at prevention through vaccination. It's also important to be able to tackle the virus once it gains a foothold in the human body. That’s where the new anti-virus pill comes into play.
Pfizer says the company may generate as much as 20 million in new local revenue and upwards of 50 million for the region due to the expansion over the next few years. The new plan initially will be assigned to the manufacture of the pain killer Dynastat. It is used primarily as a post-operative medication.